Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity.

[1]  G. Viola,et al.  Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas. , 2023, European journal of medicinal chemistry.

[2]  G. Andrei,et al.  Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors. , 2023, European journal of medicinal chemistry.

[3]  Wen-wei You,et al.  Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors. , 2022, European journal of medicinal chemistry.

[4]  Wen-wei You,et al.  Efficient synthesis and evaluation of novel 6-arylamino-[1,2,4]triazolo[4,3-a]pyridine derivatives as antiproliferative agents. , 2022, Bioorganic & medicinal chemistry letters.

[5]  L. Cascione,et al.  Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas. , 2022, European journal of medicinal chemistry.

[6]  Qiong Chen,et al.  A mini-review on synthesis and antiviral activity of natural product oxetanocin A derivatives. , 2022, Bioorganic & medicinal chemistry.

[7]  M. Hranjec,et al.  Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: Design, synthesis, biological activity in vitro and computational analysis. , 2022, Bioorganic chemistry.

[8]  A. Cavalli,et al.  Novel fragment-derived colchicine-site binders as microtubule-destabilizing agents. , 2022, European journal of medicinal chemistry.

[9]  L. Bagella,et al.  Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity. , 2022, European journal of medicinal chemistry.

[10]  Changshui Wang,et al.  Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents. , 2022, Bioorganic chemistry.

[11]  Wen-wei You,et al.  Concise synthesis and preliminary biological evaluation of new triazolylthioacetone derivatives bearing pyridine, pyrazine, and 3,4,5-trimethoxybenzyl fragment. , 2022, Bioorganic & medicinal chemistry letters.

[12]  Ming-Ju Huang,et al.  Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. , 2021, European journal of medicinal chemistry.

[13]  Guangfu Yang,et al.  Fragment-based drug design facilitates selective kinase inhibitor discovery. , 2021, Trends in pharmacological sciences.

[14]  Wen-wei You,et al.  Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines. , 2021, European journal of medicinal chemistry.

[15]  Ruo-Jun Man,et al.  Discovery of novel indole‐1,2,4‐triazole derivatives as tubulin polymerization inhibitors , 2021, Drug development research.

[16]  G. Viola,et al.  Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors. , 2020, European journal of medicinal chemistry.

[17]  P. Tassone,et al.  Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types , 2020, Journal of medicinal chemistry.

[18]  Peng-Ju Chen,et al.  Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study. , 2020, European journal of medicinal chemistry.

[19]  Wen-wei You,et al.  Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors. , 2020, European journal of medicinal chemistry.

[20]  A. Brancale,et al.  Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors. , 2020, European journal of medicinal chemistry.

[21]  Guangfu Yang,et al.  An overview of spirooxindole as a promising scaffold for novel drug discovery , 2020, Expert opinion on drug discovery.

[22]  M. Magiera,et al.  The tubulin code and its role in controlling microtubule properties and functions , 2020, Nature Reviews Molecular Cell Biology.

[23]  N. O’Boyle,et al.  Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review , 2020, Pharmaceuticals.

[24]  S. Emami,et al.  Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents. , 2019, Bioorganic chemistry.

[25]  Wen-wei You,et al.  Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities. , 2019, Bioorganic chemistry.

[26]  Menghua Liu,et al.  Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect. , 2019, European journal of medicinal chemistry.

[27]  B. Ky,et al.  Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management , 2018, Gynecologic Oncology Research and Practice.

[28]  C. Zhan,et al.  Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues. , 2010, Journal of the American Chemical Society.

[29]  Zhong-Chang Wang,et al.  Tubulin inhibitors binding to colchicine-site: A Review from 2015 to 2019. , 2019, Current medicinal chemistry.